Trump vows to crush weak Joe Biden in US 2024 polls
Donald Trump vowed Thursday to "crush" Joe Biden in the 2024 election, warning that the United States will descend into "anarchy" if the Republican billionaire isn't returned to office.
Global
Fox News and Tucker Carlson agree to part ways
Fox News and its top-rated host, Tucker Carlson, have agreed to part ways after parent company Fox Corp settled a $787.5 million defamation lawsuit in which Carlson played a significant role.
Dominic Raab resigns as UK deputy PM over bullying scandal
In response to claims of bullying behavior in the Ministry of Justice and other Whitehall agencies, Dominic Raab, the former Justice Secretary and Deputy Prime Minister, has resigned from his position.
Oil prices surge as producers unveil shock output cut
Oil prices surged on Monday following the decision by major producers to cut output by more than a million barrels per day.
Florida to ban LGBTQ+ education in schools as DeSantis eyes big spot
The Republican-led state of Florida is expected to expand the controversial "Don't Say Gay" law to ban the teaching of sexual orientation and gender identity in all school grades.
Netanyahu faces critics in German due to Israeli controversial reforms
Israeli Prime Minister Benjamin Netanyahu's controversial legal reforms have prompted Germany's leaders to urge him to reconsider the changes.
Trump vows to end insane US education system upon return to office
Former President Donald Trump has criticized the "insane" US education system and promised to bring back "common sense" schooling as part of his "America First" campaign platform.
Macron, Sunak seal big UK-France migrant deal in reset summit
British Prime Minister, Rishi Sunak, and French President, Emmanuel Macron, announced on Friday a new deal worth over 500 million euros to combat illegal cross-Channel migration.
Risks to safety prevent Neuralink from testing brain chips on people
The specifics of Neuralink's trial proposalof a ground-breaking brain implant to treat untreatable conditions, the FDA's rejection, or the scope of the agency's concerns have not been made public.
STUDY: Third person cured of HIV after stem cell transplant
According to a research released on Monday, a man known as "the Düsseldorf patient" has become the third person to be pronounced HIV-free following a stem cell transplant that also treated his leukaemia.
